The cancer‐suppressive effect of IL‐1β was confirmed in a mouse model for myeloma showing that IL‐1β (as well as IL‐1α) neutralization by anakinra severely impaired myeloma clearance by tumor‐specific Th1 cells and tumor‐infiltrating macrophages.162. This evidence concerns the gene IL1A and neoplasm.